![]() |
|
|
Vol. 281, Issue 2, 611-617, 1997
Department of Medicinal Chemistry, School of Pharmacy, University
of Washington, Seattle, Washington
Recent studies on the mechanism by which disulfiram inhibits aldehyde
dehydrogenase have provided evidence for the formation of reactive
intermediates that are thought to carbamoylate, and thereby inactivate
the enzyme. In our study, rats were dosed with either disulfiram (0.25 mmol kg
1 i.p.) or its reduced metabolite
diethyldithiocarbamate (DDTC; 0.5 mmol kg
1
i.p.) and urine was collected for the analysis of metabolites derived
from putative reactive intermediates. By means of ionspray LC-MS/MS,
two novel N-acetylcysteine (NAC) conjugates,
i.e.,
N-acetyl-S-(N, N-diethylcarbamoyl)cysteine and
N-acetyl-S-(N,
N-diethylthiocarbamoyl)cysteine, were identified in urine
specimens. Quantitative analyses indicated that, over the 0- to 24-hr
period after drug administration, urinary excretion of
N-acetyl-S-(N,
N-diethylcarbamoyl)cysteine accounted for 7.5 ± 4.0 and
6.2 ± 1.0%, respectively, of the dose of disulfiram and
diethyldithiocarbamate, while the corresponding thiocarbamoyl conjugate, N-acetyl-S-(N,
N-diethylthiocarbamoyl)cysteine, accounted for a further
0.5 ± 0.3 and 0.3 ± 0.1%, respectively, of the dose. These
conjugates are believed to derive from reactive sulfoxide and sulfone
metabolites of disulfiram, namely S-methyl-N,
N-diethylthiocarbamate sulfoxide (DETC-MeSO),
S-methyl-N, N-diethylthiocarbamate
sulfone (DETC-MeSO2), S-methyl-N,
N-diethyldithiocarbamate sulfoxide (DDTC-MeSO) and
S-methyl-N, N-diethyldithiocarbamate
sulfone (DDTC-MeSO2), which were found to carbamoylate
N-acetylcysteine in vitro with the
following rank order of reactivity: DDTC-MeSO2 > DETC-MeSO2 > DDTC-MeSO > DETC-MeSO. In
vitro experiments with aldehyde dehydrogenase showed that all
four S-oxygenated metabolites inhibited the enzyme effectively. Furthermore, inclusion of NAC in incubation media attenuated significantly the inhibition by DDTC-MeSO2,
DETC-MeSO2 and DDTC-MeSO, but had little effect on that by
DETC-MeSO. Our results are consistent with the hypothesis that
disulfiram and diethyldithiocarbamate undergo activation by a sequence
of metabolic reactions leading to the formation of electrophilic
S-methyl sulfoxides and sulfones that carbamoylate, and
thereby inhibit, aldehyde dehydrogenase and possibly other enzymes.
This article has been cited by other articles:
![]() |
P. J. Murphy The Development of Drug Metabolism Research as Expressed in the Publications of ASPET: Part 3, 1984-2008 Drug Metab. Dispos., October 1, 2008; 36(10): 1977 - 1982. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Salva, J. M. Jansat, A. Martinez-Tobed, and J. M. Palacios Identification of the Human Liver Enzymes Involved in the Metabolism of the Antimigraine Agent Almotriptan Drug Metab. Dispos., April 1, 2003; 31(4): 404 - 411. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Emery, C. Jubert, K. E. Thummel, and E. D. Kharasch Duration of Cytochrome P-450 2E1 (CYP2E1) Inhibition and Estimation of Functional CYP2E1 Enzyme Half-Life after Single-Dose Disulfiram Administration in Humans J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 213 - 219. [Abstract] [Full Text] |
||||